Text Size

A Study of Drug-Induced Kidney Disease

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00729014
First received: August 1, 2008
Last updated: NA
Last verified: May 2008
History: No changes posted
  Purpose

The purpose of this study is to identify incidence of Chinese herb nephropathy in a medical center


Condition
End Stage Renal Disease

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: A Study of Drug-Induced Kidney Disease

Resource links provided by NLM:

MedlinePlus related topics: Kidney Failure
U.S. FDA Resources

Further study details as provided by National Taiwan University Hospital:

Primary Outcome Measures:
  • The incidence of herbal nephropathy [ Time Frame: 5 years ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • The epidemiology of primary diagnosis for end stage renal disease in Taiwan [ Time Frame: 5 years ] [ Designated as safety issue: No ]

Estimated Enrollment: 2000
Study Start Date: May 2008
Estimated Primary Completion Date: September 2008 (Final data collection date for primary outcome measure)
Detailed Description:

This is a retrospective study, by computer screening, chart review and phone survey to find herbal nephropathy and determine the cause-relationship.

Using ICD-9-CM code as a tool to screen the newly diagnosed ESRD in NTUH computer data base, and divided patients into those with underlying disease(s) that cause the renal failure and those without.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

a medical center

Criteria

Inclusion Criteria:

  • patient who was newly diagnosed as end stage renal disease who need dialysis

Exclusion Criteria:

  • started dialysis before 2000
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00729014

Contacts
Contact: Fe-Lin L Wu, MSCP, Ph.D 886-2-23123456 ext 8389 flwu@ntu.edu.tw
Contact: Kwan-Dun Wu, MD, Ph.D 886-2-23123456 ext 5014 kdwu@ntuh.gov.tw

Locations
Taiwan
National Taiwan University Hospital Recruiting
Taipei, Taiwan, 100
Contact: Fe-Lin L. Wu, MSCP,Ph D     +886-2-23123456 ext 8389     flwu@ntu.edu.tw    
Contact: Kwan-Dun Wu, MD, PhD     +886-2-23123456 ext 5014     kdwu@ntuh.gov.tw    
Principal Investigator: Fe-Lin L. Wu, Ph D            
Sponsors and Collaborators
National Taiwan University Hospital
Department of Health, Executive Yuan, R.O.C. (Taiwan)
Investigators
Principal Investigator: Kwan-Dun Wu, MD, PhD National Taiwan University Hospital
  More Information

No publications provided

Responsible Party: Fe-Lin L Wu, Ph.D., Director, National Taiwan University Hospital
ClinicalTrials.gov Identifier: NCT00729014     History of Changes
Other Study ID Numbers: 200804062R
Study First Received: August 1, 2008
Last Updated: August 1, 2008
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
herbal nephropathy
Chinese herbal nephropathy
nephrotoxicity
 renal disease
adverse drug reaction
Chinese herbal medicine

Additional relevant MeSH terms:
Kidney Diseases
Kidney Failure, Chronic
Urologic Diseases
Renal Insufficiency, Chronic
Renal Insufficiency

ClinicalTrials.gov processed this record on June 18, 2013